Why aren't the US Centers for Disease Control and Food and Drug Administration speaking with one voice on flu?

BMJ ◽  
2015 ◽  
Vol 350 (feb05 8) ◽  
pp. h658-h658 ◽  
Author(s):  
J. Lenzer
Keyword(s):  
Disease Control ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
The Us ◽  
Centers For Disease Control

Response to Alert on Possible Infections with Mycobacterium chimaera From Contaminated Heater-Cooler Devices in Hospitals Participating in the Canadian Nosocomial Infection Surveillance Program (CNISP)

2018 ◽  
Vol 39 (4) ◽  
pp. 482-484 ◽  
Author(s):  
Dominik Mertz ◽  
Jennifer Macri ◽  
Susy Hota ◽  
Kanchana Amaratunga ◽  
Ian Davis ◽  
...  
Keyword(s):  
Informed Consent ◽  
Nosocomial Infection ◽  
Disease Control ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Infect Control Hosp ◽  
Surveillance Program ◽  
Infection Surveillance ◽  
The Us ◽  
Control And Prevention

Canadian hospitals were made aware of the risk of Mycobacterium chimaera infection associated with heater-cooler units (HCUs) through alerts issued by the US food and Drug Administration (FDA) and the US Centers for Disease Control and Prevention (CDC). In response, most hospitals conducted retrospective reviews for infections, informed exposed patients, and initiated a requirement for informed consent with HCU use.Infect Control Hosp Epidemiol 2018;39:482–484

scholarly journals The Erosion of Public Trust and SARS-CoV-2 Vaccines— More Action is Needed

2021 ◽  
Author(s):  
Ari Nahum ◽  
Dimitri M Drekonja ◽  
Jonathan D Alpern
Keyword(s):  
Social Media ◽  
Disease Control ◽  
Health Systems ◽  
Drug Administration ◽  
Food And Drug Administration ◽  
Public Trust ◽  
Regulatory Process ◽  
Vaccine Hesitancy ◽  
Social Media Platforms ◽  
Centers For Disease Control

Abstract As states and health systems prepare to deliver SARS-CoV-2 vaccines to the American public, a confluence of factors has the potential to interfere with these efforts: Misinformation about COVID-19, vaccine hesitancy, and the erosion of the American public’s trust in the vaccine regulatory process due to recent and ongoing events. Broad action is needed to address these issues, including improved and consistent communication by the Food and Drug Administration, restoration of the Centers for Disease Control as an independent and science-driven institution, and more aggressive policies to counteract misinformation, particularly on social media platforms.

scholarly journals 2020 FDA TIDES (Peptides and Oligonucleotides) Harvest

2021 ◽  
Vol 14 (2) ◽  
pp. 145
Author(s):  
Othman Al Musaimi ◽  
Danah Al Shaer ◽  
Fernando Albericio ◽  
Beatriz de la Torre
Keyword(s):  
Adverse Effects ◽  
Global Health ◽  
Drug Administration ◽  
Mode Of Action ◽  
Chemical Structure ◽  
Food And Drug Administration ◽  
Health Crisis ◽  
New Drug ◽  
Target Mode ◽  
The Us

2020 has been an extremely difficult and challenging year as a result of the coronavirus disease 2019 (COVID-19) pandemic and one in which most efforts have been channeled into tackling the global health crisis. The US Food and Drug Administration (FDA) has approved 53 new drug entities, six of which fall in the peptides and oligonucleotides (TIDES) category. The number of authorizations for these kinds of drugs has been similar to that of previous years, thereby reflecting the consolidation of the TIDES market. Here, the TIDES approved in 2020 are analyzed in terms of chemical structure, medical target, mode of action, and adverse effects.

Sign in / Sign up

Export Citation Format

Share Document